Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Figures corrected afterwards (2025).
Gross margin
€ -138,661
▲ 25% vs 2024
Profit
Caution€ -354,671
▲ 7% vs 2024
Debts
Low€ 628,260
▲ 16% vs 2024
Sagitta Biotech from Liège, company number BE0724569610, closed financial year 2025 with a result of € -354,671 after tax. For that financial year Sagitta Biotech recorded a gross margin of € -138,661 and equity of € 353,411. Compared with financial year 2024, the result moved from € -379,488 to € -354,671. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 15, 2026.
What happened at Sagitta Biotech?
What happened at Sagitta Biotech in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- NEMESIS CONSULTING SA SA stepped down as director. NBB
- NOSHAQ PARTNERS SRL SRL stepped down as director. NBB
- Didier Allaer stepped down as director. NBB
- Corrected annual accounts filed for financial year 2025. Source: NBB ↗
- NOSHAQ PARTNERS SRL SRL became a director. NBB
- Didier Allaer became a director. NBB
- New establishment in Liège. KBO
- NEMESIS CONSULTING SA SA became a director. NBB
In short
From € 2,405 loss in 2021 to € 354,671 loss in 2025.
A new publication or filing at Sagitta Biotech? We notify you, reason included.
Follow Sagitta BiotechNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Damien Benjamin
since 2019 · until 2029
Director · represented by Schynts Frédéric
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE +174 more
since 2023 · until 2029
Establishments
Establishment units
Physical locations of this company
Avenue Hippocrate 5 box GIGA
4000 Liège
Avenue Pré-Aily 10
4031 Liège
Active since 4 April 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
XeroThera Europe
€ 196,870 gross margin · 2025
QUIDDITAS
€ 175,986 gross margin · 2025
ARTIALIS same network
€ 320,267 gross margin · 2024
Temple OrthoBiologics
€ -225,322 gross margin · 2025
BRENUS PHARMA BELGIUM
+1 more
Details
- Company number
- 0724.569.610
- VAT number
- BE 0724.569.610
- Registered office
- Avenue Hippocrate 5 bus GIGA, 4000 Liège
- Names & denominations
- Sagitta Biotech
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2019
- Peppol
- Active · Active since 24 Mar 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied